GILL DAVID N Insider Trading
Get the latest insider transactions of GILL DAVID N. GILL DAVID N is Senior Vice President and CFO in CTI MOLECULAR IMAGING INC ($CTMI) and in STRATA Skin Sciences, Inc. ($MELA) and Director in STRATA Skin Sciences, Inc. ($MELA) and Director in HISTOGENICS CORP ($HSGX) and Director in CEMPRA, INC. ($CEMP) and Director in Evolus, Inc. ($EOLS) and Chief Financial Officer in EndoChoice Holdings, Inc. ($GI) and President and CFO in EndoChoice Holdings, Inc. ($GI) and Director in Strongbridge Biopharma plc ($SBBP) and Director in Y-mAbs Therapeutics, Inc. ($YMAB). Discover the current value of GILL DAVID N shares.
Address: 810 INNOVATION DRIVE KNOXVILLE 37932TN
GILL DAVID N is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
CTMI | CTI MOLECULAR IMAGING INC | Senior Vice President and CFO | 0 | 0.00 |
HSGX | Ocugen, Inc. | Director | 14,000 | 23,240.00 |
GI | EndoChoice Holdings, Inc. | President and CFO, Chief Financial Officer | 0 | 0.00 |
MLNT | MELINTA THERAPEUTICS, INC. /NEW/ | Director | 6,000 | 18,000.00 |
EOLS | Evolus, Inc. | Director | 24,313 | |
MELA | STRATA Skin Sciences, Inc. | 64,694 | 72,457.28 | |
SBBP | Strongbridge Biopharma plc | Director | 74,896 | |
YMAB | Y-mAbs Therapeutics, Inc. | Director | 2,000 |
Insider Trading Transactions of GILL DAVID N
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | 0.00 | 19,313 | 0 | 24,313 |
Jan 20 2021 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Buy | 11.16 | 2,000 | 22,320 | 2,000 |
Jan 20 2021 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Sell | 46.52 | 2,000 | 93,045 | 0 |
Jan 20 2021 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Option Exercise | 11.16 | 2,000 | 22,320 | 24,000 |
Nov 20 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Buy | 11.16 | 2,000 | 22,320 | 2,000 |
Nov 20 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Sell | 45.77 | 2,000 | 91,530 | 0 |
Nov 20 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Option Exercise | 11.16 | 2,000 | 22,320 | 26,000 |
Nov 05 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Buy | 11.16 | 4,000 | 44,640 | 4,000 |
Nov 05 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Sell | 45.00 | 4,000 | 180,000 | 0 |
Nov 05 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Option Exercise | 11.16 | 4,000 | 44,640 | 28,000 |
Sep 28 2020 | SBBP | Strongbridge Biopharma pl ... | GILL DAVID N | Director | Buy | 2.13 | 8,000 | 17,040 | 74,896 |
Sep 04 2020 | SBBP | Strongbridge Biopharma pl ... | GILL DAVID N | Director | Sell | 3.61 | 23,104 | 83,405 | 66,896 |
Jun 24 2020 | YMAB | Y-mAbs Therapeutics, Inc. | GILL DAVID N | Director | Option Exercise | 48.67 | 16,000 | 778,720 | 16,000 |
May 15 2020 | SBBP | Strongbridge Biopharma pl ... | GILL DAVID N | Director | Buy | 0.00 | 40,000 | 0 | 90,000 |
May 15 2020 | SBBP | Strongbridge Biopharma pl ... | GILL DAVID N | Director | Buy | 0.00 | 40,000 | 0 | 90,000 |
Jan 24 2020 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | 10.19 | 23,458 | 239,037 | 23,458 |
Nov 26 2019 | MELA | STRATA Skin Sciences, Inc ... | GILL DAVID N | Buy | 0.00 | 18,293 | 0 | 64,694 | |
Jun 14 2019 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | 13.65 | 2,000 | 27,300 | 5,000 |
Jun 12 2019 | MLNT | MELINTA THERAPEUTICS, INC ... | GILL DAVID N | Director | Option Exercise | 0.00 | 30,000 | 0 | 30,000 |
Jan 25 2019 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | 16.19 | 14,500 | 234,755 | 14,500 |
Dec 17 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | 12.77 | 3,000 | 38,300 | 3,000 |
Dec 17 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | 12.77 | 3,000 | 38,300 | 3,000 |
Jun 19 2018 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | 2.97 | 25,000 | 74,250 | 25,000 |
Jun 14 2018 | MLNT | MELINTA THERAPEUTICS, INC ... | GILL DAVID N | Director | Option Exercise | 7.45 | 25,000 | 186,250 | 25,000 |
Jun 14 2018 | MLNT | MELINTA THERAPEUTICS, INC ... | GILL DAVID N | Director | Option Exercise | 7.45 | 9,100 | 67,795 | 9,100 |
Jun 14 2018 | MLNT | MELINTA THERAPEUTICS, INC ... | GILL DAVID N | Director | Option Exercise | 7.45 | 25,000 | 186,250 | 25,000 |
Jun 14 2018 | MLNT | MELINTA THERAPEUTICS, INC ... | GILL DAVID N | Director | Option Exercise | 7.45 | 9,100 | 67,795 | 9,100 |
Jun 11 2018 | MELA | STRATA Skin Sciences, Inc ... | GILL DAVID N | Director | Option Exercise | 2.07 | 26,570 | 55,000 | 26,570 |
May 30 2018 | MLNT | MELINTA THERAPEUTICS, INC ... | GILL DAVID N | Director | Buy | 6.09 | 5,000 | 30,450 | 6,000 |
Apr 26 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | 8.01 | 22,696 | 181,795 | 22,696 |
Aug 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | 1.81 | 3,000 | 5,439 | 14,000 |
Jun 14 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | 1.70 | 25,000 | 42,500 | 25,000 |
May 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | 1.68 | 3,000 | 5,040 | 11,000 |
Jan 05 2017 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Option Exercise | 3.00 | 15,000 | 45,000 | 15,000 |
Jan 04 2017 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Buy | 2.94 | 5,000 | 14,720 | 5,000 |
Dec 19 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | 1.58 | 10,000 | 15,800 | 10,000 |
Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | 1.92 | 5,000 | 9,600 | 5,000 |
Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | 1.65 | 3,000 | 4,950 | 8,000 |
Nov 23 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | President and CFO | Sell | 8.00 | 125,445 | 1,003,560 | 0 |
Nov 23 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | President and CFO | Sell | 8.00 | 38,585 | 308,680 | 0 |
Nov 23 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | President and CFO | Option Exercise | 5.31 | 32,230 | 171,141 | 0 |
Nov 23 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | President and CFO | Option Exercise | 16.01 | 53,825 | 861,738 | 0 |
Mar 31 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | President and CFO | Buy | 0.00 | 14,826 | 0 | 137,405 |
Mar 31 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | President and CFO | Option Exercise | 5.31 | 32,230 | 171,141 | 32,230 |
Mar 10 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | Chief Financial Offic ... | Buy | 4.70 | 2,000 | 9,400 | 25,130 |
Mar 07 2016 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | Chief Financial Offic ... | Buy | 4.77 | 5,000 | 23,850 | 23,130 |
Jan 05 2016 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Option Exercise | 31.13 | 15,000 | 466,950 | 15,000 |
Aug 17 2015 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | Chief Financial Offic ... | Buy | 0.00 | 53,825 | 0 | 133,049 |
Aug 17 2015 | GI | EndoChoice Holdings, Inc. | GILL DAVID N | Chief Financial Offic ... | Option Exercise | 16.01 | 53,825 | 861,738 | 53,825 |
Jun 26 2015 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | 6.86 | 6,800 | 46,648 | 6,800 |
May 06 2005 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 20.50 | 93,000 | 1,906,500 | 0 |
May 06 2005 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 20.50 | 3,200 | 65,600 | 0 |
May 06 2005 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 20.50 | 3,200 | 65,600 | 0 |
May 06 2005 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 0.00 | 242,547 | 0 | 0 |
Jan 19 2005 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Buy | 4.69 | 9,700 | 45,469 | 93,000 |
Jan 19 2005 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 4.69 | 9,700 | 45,469 | 171,800 |
Oct 19 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Buy | 4.69 | 10,501 | 49,223 | 83,300 |
Oct 19 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 4.69 | 10,501 | 49,223 | 181,500 |
Oct 18 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Buy | 4.69 | 12,799 | 59,995 | 72,799 |
Oct 18 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 4.69 | 12,799 | 59,995 | 192,001 |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Buy | 0.00 | 60,000 | 0 | 60,000 |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 4.69 | 51,200 | 240,000 | 204,800 |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 4.69 | 51,200 | 240,000 | 51,200 |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 5.56 | 12,800 | 71,200 | 51,200 |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 5.56 | 12,800 | 71,200 | 12,800 |
Jun 04 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 13.72 | 15,000 | 205,800 | 0 |
May 13 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 14.07 | 10,000 | 140,700 | 15,000 |
Mar 03 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 16.49 | 14,000 | 230,889 | 25,000 |
Feb 19 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Sell | 17.67 | 16,000 | 282,720 | 39,000 |
Feb 12 2004 | CTMI | CTI MOLECULAR IMAGING INC | GILL DAVID N | Senior Vice President ... | Option Exercise | 15.05 | 19,547 | 294,182 | 19,547 |